Pharma Navigatio AB
ActiveKey figures
Key figures
2023Summary: Pharma Navigatio AB
What kind of company is it?
Pharma Navigatio AB (org. no. 556807-8751) is a limited company (AB). The company was registered in 2010 and has existed for 16 years. Registered seat: Stenungsund. Industry according to Statistics Sweden: trading in securities for a limited and closed group of owners (SNI 64994).
How is the company doing financially?
The company had no net sales in financial year 2023. Net profit for 2023 was 230 161 kr. The company was profitable in all 4 reported financial years. According to the annual report, the company had no employees in financial year 2023. At the end of financial year 2023, total assets were 4 533 613 kr and equity 3 240 546 kr (equity ratio 71,5 %).
What should you look out for?
The latest digitally filed annual report is for 2023.
Where does the data come from and how up to date is it?
Company details and digitally filed annual reports come from the open data of the Swedish Companies Registration Office (Bolagsverket) and the industry code from Statistics Sweden (CC BY 2.5 SE); bolagsprofil.se updates them daily. The latest annual report is signed by one person. Data as of 2026-11-16. Changes, averages and ratios are calculated by bolagsprofil.se from open data and are not an official assessment.
Dividend
from the annual reportProposed dividend 195 000 kr.
Summary of annual reports2020–2023
| 2019/20 | 2020/21 | 2022 | 2023 | |
|---|---|---|---|---|
| Sales revenue | 2 264 000 | 290 000 | 51 000 | 0 |
| Profit for the reporting year | 646 027 | 4 519 | 8 461 | 230 161 |
| Retained earnings of previous periods | — | — | — | — |
| Total assets | 5 694 173 | 5 081 169 | 4 669 196 | 4 533 613 |
| Total liabilities | 2 121 767 | 1 694 244 | 1 463 810 | 1 293 067 |
| Total equity | 3 572 406 | 3 386 925 | 3 205 386 | 3 240 546 |
| Employees | 1 | 1 | 1 | 0 |
| Proposed dividend | — | 190 000 | 195 000 | — |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.